| Dr James G Blom, MD | |
|
3851 Piper St, Tower U, Suite Ll002, Anchorage, AK 99508-4684 | |
| (907) 212-3186 | |
| (907) 212-3665 |
| Full Name | Dr James G Blom |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 33 Years |
| Location | 3851 Piper St, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871565556 | NPI | - | NPPES |
| 4045612 | Other | TN | BLUE CROSS B/S TN INDIV. |
| 3045857 | Other | TN | BLUE CROSS TN GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | MD0000036692 (Tennessee) | Secondary |
| 2085R0001X | Radiology - Radiation Oncology | 6548 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rbs Evolution Of Alaska Llc | 3274777974 | 9 |
News Archive
Continua Health Alliance championed the use of personal connected healthcare technologies to increase veteran access to quality healthcare during last week's hearing of the House Committee on Veterans Affairs Subcommittee on Health. President and Chair of the Continua Board of Directors, Rick Cnossen, testified on behalf of the Alliance to address the issues facing veterans living in rural areas who typically receive lower quality healthcare than the general population due to lack of access.
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
Non-melanoma skin cancer is the most common form of malignancy in adult Caucasian populations, with more than a million cases recorded each year in the USA alone.
The Johns Hopkins Drug Discovery (JHDD) program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences (IOCB Prague) have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer and gastrointestinal disorders.
Researchers at Mount Sinai School of Medicine have found that grape seed polyphenols—a natural antioxidant—may help prevent the development or delay the progression of Alzheimer's disease.
› Verified 4 days ago
| Entity Name | Rbs Evolution Of Alaska Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316280209 PECOS PAC ID: 3274777974 Enrollment ID: O20130919000398 |
News Archive
Continua Health Alliance championed the use of personal connected healthcare technologies to increase veteran access to quality healthcare during last week's hearing of the House Committee on Veterans Affairs Subcommittee on Health. President and Chair of the Continua Board of Directors, Rick Cnossen, testified on behalf of the Alliance to address the issues facing veterans living in rural areas who typically receive lower quality healthcare than the general population due to lack of access.
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
Non-melanoma skin cancer is the most common form of malignancy in adult Caucasian populations, with more than a million cases recorded each year in the USA alone.
The Johns Hopkins Drug Discovery (JHDD) program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences (IOCB Prague) have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer and gastrointestinal disorders.
Researchers at Mount Sinai School of Medicine have found that grape seed polyphenols—a natural antioxidant—may help prevent the development or delay the progression of Alzheimer's disease.
› Verified 4 days ago
| Entity Name | Rbs Evolution Of Juneau Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609202282 PECOS PAC ID: 7315173358 Enrollment ID: O20131120001975 |
News Archive
Continua Health Alliance championed the use of personal connected healthcare technologies to increase veteran access to quality healthcare during last week's hearing of the House Committee on Veterans Affairs Subcommittee on Health. President and Chair of the Continua Board of Directors, Rick Cnossen, testified on behalf of the Alliance to address the issues facing veterans living in rural areas who typically receive lower quality healthcare than the general population due to lack of access.
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
Non-melanoma skin cancer is the most common form of malignancy in adult Caucasian populations, with more than a million cases recorded each year in the USA alone.
The Johns Hopkins Drug Discovery (JHDD) program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences (IOCB Prague) have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer and gastrointestinal disorders.
Researchers at Mount Sinai School of Medicine have found that grape seed polyphenols—a natural antioxidant—may help prevent the development or delay the progression of Alzheimer's disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James G Blom, MD P.o. Box 94165, Seattle, WA 98124-6465 Ph: (907) 212-3186 | Dr James G Blom, MD 3851 Piper St, Tower U, Suite Ll002, Anchorage, AK 99508-4684 Ph: (907) 212-3186 |
News Archive
Continua Health Alliance championed the use of personal connected healthcare technologies to increase veteran access to quality healthcare during last week's hearing of the House Committee on Veterans Affairs Subcommittee on Health. President and Chair of the Continua Board of Directors, Rick Cnossen, testified on behalf of the Alliance to address the issues facing veterans living in rural areas who typically receive lower quality healthcare than the general population due to lack of access.
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
Non-melanoma skin cancer is the most common form of malignancy in adult Caucasian populations, with more than a million cases recorded each year in the USA alone.
The Johns Hopkins Drug Discovery (JHDD) program, created with the mission of identifying novel drug targets arising from Johns Hopkins faculty research and translating them into new therapeutics, and the Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences (IOCB Prague) have entered into a five-year drug discovery research agreement to develop small-molecule and peptide drugs for a range of therapeutic areas including neurological diseases, cancer and gastrointestinal disorders.
Researchers at Mount Sinai School of Medicine have found that grape seed polyphenols—a natural antioxidant—may help prevent the development or delay the progression of Alzheimer's disease.
› Verified 4 days ago
Michael James Mcdonnell, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
William Patton Perry, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2751 Debarr Rd Ste B360, Anchorage, AK 99508 Phone: 907-792-7920 | |
Burl C Stephens, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 | |
Dr. Matthew Raymond Minor, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3650 Piper St Ste A, Anchorage, AK 99508 Phone: 907-339-9455 Fax: 907-339-9445 | |
Dr. Gerald Edward York Ii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3650 Piper Street Suite A, Anchorage, AK 99508 Phone: 907-222-4624 Fax: 907-222-4651 | |
John Mccormick, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2110 E Northern Lights Blvd, Anchorage, AK 99508 Phone: 907-563-3700 Fax: 907-563-3740 | |
Dr. Wandal Bryan Winn, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-339-9455 Fax: 907-339-9445 |